The risk of rash for cancer patients treated with PD-1/PD-L1 inhibitors: An updated systematic review and meta-analysis.

Jiang Q, Liu J, Li Z, Zhang C, Dang Q, Tian Y

Open source

DOI
10.1097/md.0000000000049720
Published
2026 Jul 10
Container
Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000049720,
  title = {The risk of rash for cancer patients treated with PD-1/PD-L1 inhibitors: An updated systematic review and meta-analysis.},
  author = {Jiang Q and Liu J and Li Z and Zhang C and Dang Q and Tian Y},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000049720},
  url = {https://doi.org/10.1097/md.0000000000049720}
}

RIS

TY  - JOUR
TI  - The risk of rash for cancer patients treated with PD-1/PD-L1 inhibitors: An updated systematic review and meta-analysis.
AU  - Jiang Q
AU  - Liu J
AU  - Li Z
AU  - Zhang C
AU  - Dang Q
AU  - Tian Y
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000049720
UR  - https://doi.org/10.1097/md.0000000000049720
ER  - 

APA

Q, J., J, L., Z, L., C, Z., Q, D., & Y, T. (2026). The risk of rash for cancer patients treated with PD-1/PD-L1 inhibitors: An updated systematic review and meta-analysis.. Medicine. https://doi.org/10.1097/md.0000000000049720

Source records